U.K. pharmaceutical major GlaxoSmithKline PLC is conducting an internal investigation to see whether its employees enganged in bribery in the United Arab Emirates, Reuters reported Tuesday. The move followed an email, purportedly from a Glaxo sales manager in the UAE, who alleged improper payments from the company, the report said, adding that Reuters had seen the email in question. A Glaxo spokesman confirmed a wider, previously announced investigation into possible bribery by its representatives in various Middle East nations, as well as Poland, the report said. Earlier this year, Glaxo was involved in a bribery scandal in China which resulted in a fine of more than $490 million and a criminal conviction for its former China chief.
Copyright © 2014 MarketWatch, Inc.
Continue Reading Below